Catalyst

Slingshot members are tracking this event:

Zogenix Announces Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ZGNX

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 29, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Zx008, Dravet Syndrome, Epilepsy